Acambis PLC
Summary Details
| Previous Name: | ( 5 Dec 00) Peptide Therapeutics Group PLC |
|---|---|
| ACTIVITIES: | The group develops vaccines to prevent and treat infectious diseases. A producer of smallpox vaccines, the group provides governments around the world with the full portfolio of related smallpox products required to protect their citizins against the threat of smallpox virus being used as a bioterrorist weapon. The group is establishing a travel vaccines franchise, including vaccines against yellow fever, Japanese encephalitis, dengue fever and typhoid. The group also has an advanced vaccine in development targeting the West Nile virus, which has spread to over 40 US States in the last three years |
| STATUS: | Full; ADR. |
| INDEX: | FTSE SmallCap, techMARK 100 |
| SECTOR: | Pharmaceuticals & Biotechnology |
| NO.EMP: |  (includes five years of historical data) |
| REM: | (current and last financial year) |
| GEARING: | (current and last financial year) |
| ROCE: | (current and last financial year) |
| PRELIM: | (current and last financial year) |
| NOTES: | (current and last financial year) |
| denotes that this financial data is available via Hemscott's Premium service |
|
2nd May 2006